A study to evaluate RINTEGA administered after surgery but prior to and concurrently with chemoradiation in newly diagnosed glioblastoma patients.

Trial Profile

A study to evaluate RINTEGA administered after surgery but prior to and concurrently with chemoradiation in newly diagnosed glioblastoma patients.

Planning
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Rindopepimut (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2016 New trial record
    • 25 Feb 2016 According to Celldex Therapeutics Inc media release, the company expects to initiate this trial in the second half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top